#Pain Fellowship

[asianpainacademy]

Chronic Pain Fellowship Program - Special Course on Pain Intervention Techniques

Are you in the pain management profession? Looking for advanced pain management courses that you can get your patients rid of chronic pain without harsh and heavy pain medications? Then this blog is for you. Today, we will discuss the program on chronic pain fellowship in India. You can get to know how you can enroll for such a course in India with eligibility criteria, course duration, and benefits of the course for your future.

What is Chronic Pain Management Treatment?

Today’s fast-forward digital-platform-centered lifestyle compels us to suffer from various pains. The most common pains people suffer these days are back (upper and lower) pain, shoulder pain, pain in the scapula, spine pain, neck pain, shoulder pain, waist pain, knee pain, wrist pain, and so on. Pain that resists for more than 3 months with the same or increased frequency is called chronic pain. Chronic pain management treatments are those that help patients get back to their regular lifestyle and work with zero-invasion pain management techniques. 

Who Can Enrol In the Chronic Pain Fellowship Program In India?

Medical professionals who have completed an MD or DNB in anesthesia, an orthopedic, a radiologist, a physical rehabilitation specialist, an MBBS doctor, or a candidate who has completed a Diploma/Degree from a recognized institute in anaesthesiology, neurosurgery, orthopedics, or radiodiagnosis can enroll for the chronic pain fellowship program in India. 

Duration of the Chronic Pain Fellowship Program

The course duration counts on the course structure and volume. In general, the 3-month fellowship program is chosen by medical practitioners. After the completion of the course, a medical practitioner becomes well aware of the pain management techniques and equipment and applies non-invasive techniques to get their patients rid of chronic pain with pharmacologic, non-pharmacologic pain intervention techniques, alternative therapies, non-opioid analgesic, and psychological approaches. 

Conclusion, 

A program of Chronic Pain Fellowship in India helps a medical professional to become recognized as a special pain management doctor. After successful completion of the course, you can work as a pain management specialist in clinics that deal with chronic pain diagnosis and pain intervention treatment. 

[andromeda3116]

people actually went on about how game of thrones made it socially acceptable to be a fantasy nerd, as though the lord of the rings movies hadn't been released less than a decade earlier and left far greater cultural ripples and i am just

got may have made the adults feel better about liking fantasy, but lotr got into the kids' heads when they (we) were just young and impressionable enough to be absolutely transported and emotionally rewritten by don't you leave him, samwise gamgee and my brother, my captain, my king and and rohan will answer

lotr was rewriting entire generations' brain chemistry long before asoiaf and so obviously it's not fair to compare any post-lotr fantasy novel to it, and each book series was trying to do different things within their own spheres and so that also is not a fair comparison, but in terms of the cultural impact of the adaptations that came out within a decade of each other, saying that it was game of thrones that made fantasy mainstream is baffling

game of thrones could only run because the lord of the rings movies laid the path, and i will die on this hill

[tolkien-povs]

POV:

You read a few Kidnap-Fam fics, most of which portray Maglor and Maedhros' relationship as strong but tsundere. Then their relationship with Elros and Elrond becomes stronger, and they seem to be a happy but dysfunctional family.

Then you realise that Maedhros kills himself, and Maglor wanders the shores everafter.

[fippydarkpaw]

I just cannot engage with Lord of the Rings in typical fandom style. That is a religious text to me.

[doctorweebmd]

afa;ldf;lakdflk;asdf urgh sorry i've been MIA i unexpectedly got super busy with the grant and my grand rounds and having to pick up shifts for people with emergencies/illnesses/moving PLUS my 'graduation' is tomorrow so i'm all over the place AHHHHH

[goldkirk]

[goldeunoias]

Oh I truly do love my mother I do but getting her to understand some things is truly a battle of attrition 😭

[gemstarstarlight]

Shoutout to my pastor who, upon hearing that I struggle with painful periods and anxiety that literally gives me insomnia, but also have never been to a doctor in my entire 23 years of life,

grabbed me by the shoulders,

shook me back and forth, gently but still very much like one shakes a toddler,

and said, “Crystal, get a doctor!”

[beyonddarkness]

Just a shot-in-the-dark prediction, in light of the latest from FoF...

me, after 1x08: "The PAIN and LOSS of season 1! I may never recover!"

after season 2:

[tenth-sentence]

The leaves seemed to hiss above their heads with a sound of pain and anger.

"The Lord of the Rings: The Fellowship of the Ring" - J.R.R. Tolkien

[jcmarchi]

MIT Faculty Founder Initiative announces three winners of entrepreneurship awards

New Post has been published on https://thedigitalinsider.com/mit-faculty-founder-initiative-announces-three-winners-of-entrepreneurship-awards/

MIT Faculty Founder Initiative announces three winners of entrepreneurship awards

Patients with intractable cancers, chronic pain sufferers, and people who depend on battery-powered medical implants may all benefit from the ideas presented at the 2023-24 MIT-Royalty Pharma Prize Competition’s recent awards. This year’s top prizes went to researchers and biotech entrepreneurs Anne Carpenter, Frederike Petzschner, and Betar Gallant ’08, SM ’10, PhD ’13.

MIT Faculty Founder Initiative Executive Director Kit Hickey MBA ’13 describes the time and hard work the three awardees and other finalists devoted to the initiative and its mission of cultivating female faculty in biotech to cross the chasm between laboratory research and its clinical application.

“They have taken the first brave step of getting off the bench when they already work seven days a week. They have carved out time from their facilities, from their labs, from their lives in order to put themselves out there and leap into entrepreneurship,” Hickey says. “They’ve done it because they each want to see their innovations out in the world improving patients’ lives.”

Carpenter, senior director of the Imaging Platform at the Broad Institute of MIT and Harvard, where she is also an institute scientist, won the competition’s $250,000 2023-24 MIT-Royalty Pharma Faculty Founder Prize Competition Grand Prize. Carpenter specializes in using microscopy imaging of cells and computational methods such as machine learning to accelerate the identification of chemical compounds with therapeutic potential to, for instance, shrink tumors. The identified compounds are then tested in biological assays that model the tumor ecosystem to see how the compounds would perform on actual tumors.

Carpenter’s startup, SyzOnc, launched in April, a feat Carpenter associates with the assistance provided by the MIT Faculty Founder Initiative. Participants in the program receive mentorship, stipends, and advice from industry experts, as well as help with incorporating, assembling a management team, fundraising, and intellectual property strategy.

“The program offered key insights and input at major decision points that gave us the momentum to open our doors,” Carpenter says, adding that participating “offered validation of our scientific ideas and business plan. That kind of credibility is really helpful to raising funding, particularly for those starting their first company.”

Carpenter says she and her team will employ “the best biological and computational advancements to develop new therapies to fight tumors such as sarcoma, pancreatic cancer, and glioblastoma, which currently have dismal survival rates.”

The MIT Faculty Founder Initiative was begun in 2020 by the School of Engineering and the Martin Trust Center for MIT Entrepreneurship, based on research findings by Sangeeta Bhatia, the Wilson Professor of Health Sciences and Technology, professor of electrical engineering and computer science, and faculty director of the MIT Faculty Founder Initiative; Susan Hockfield, MIT Corporation life member, MIT president emerita, and professor of neuroscience; and Nancy Hopkins, professor emerita of biology. An investigation they conducted showed that only about 9 percent of MIT’s 250 biotech startups were started by women, whereas women made up 22 percent of the faculty, as was presented in a 2021 MIT Faculty Newsletter.

That data showed that “technologies from female labs were not getting out in the world, resulting in lost potential,” Hickey says.

“The MIT Faculty Founder Initiative plays a pivotal role in MIT’s entrepreneurship ecosystem. It elevates visionary faculty working on solutions in biotech by providing them with critical mentorship and resources, ensuring these solutions can be rapidly scaled to market,” says Anantha Chandrakasan, MIT’s chief innovation and strategy officer, dean of engineering, and Vannevar Bush Professor of Electrical Engineering and Computer Science.

The MIT Faculty Founder Initiative Prize Competition was launched in 2021. At this year’s competition, the judges represented academia, health care, biotech, and financial investment. In addition to awarding a grand prize, the competition also distributed two $100,000 prizes, one to a researcher from Brown University, the first university to collaborate with MIT in the entrepreneurship program.

This year’s winner of the $100,000 2023-24 MIT-Royalty Pharma Faculty Founder Prize Competition Runner-Up Prize was Frederike Petzschner, assistant professor at the Carney Institute for Brain Science at Brown, for her SOMA startup’s digital pain management system, which helps sufferers to manage and relieve chronic pain.

“We leverage cutting-edge technology to provide precision care, focusing specifically on personalized cognitive interventions tailored to each patient’s unique needs,” she says.

With her startup on the verge of incorporating, Petzschner says, “without the Faculty Finder Initiative, our startup would still be pursuing commercialization, but undoubtedly at a much earlier and perhaps less structured stage.”

“The constant support from the program organizers and our mentors was truly transformative,” she says.

Gallant, associate professor of mechanical engineering at MIT and winner of the $100,000 2023-24 MIT-Royalty Pharma Faculty Founder Prize Competition Breakthrough Prize, is leading the startup Halogen. An expert on advanced battery technologies, Gallant and her team have developed high-density battery storage to improve the lifetime and performance of such medical devices as pacemakers.

“If you can extend lifetime, you’re talking about longer times between invasive replacement surgeries, which really affects patient quality of life,” Gallant told MIT News in a 2022 interview.

Jim Reddoch, executive vice president and chief scientific officer of sponsor Royalty Pharma, emphasized his company’s support for both the competition and the MIT Faculty Finder Initiative program.

“Royalty Pharma is thrilled to support the 2023-2024 MIT-Royalty Pharma Prize Competition and accelerate life sciences innovation at leading research institutions such as MIT and Brown,” Reddoch says. “By supporting the amazing female entrepreneurs in this program, we hope to catalyze more ideas from the lab to biotech companies and eventually into the hands of patients.”

Bhatia has referred to the MIT Faculty Founder Initiative as a “playbook” on how to direct female faculty’s high-impact technologies that are not being commercialized into the world of health care.

“To me, changing the game means that when you have an invention in your lab, you’re connected enough to the ecosystem to know when it should be a company, and to know who to call and how to get your first investors and how to quickly catalyze your team — and you’re off to the races,” Bhatia says. “Every one one of those inventions can be a medicine as quickly as possible. That’s the future I imagine.”

Co-founder Hockfield referred to MIT’s role in promoting entrepreneurship in remarks at the award ceremony, alluding to Brown University’s having joined the effort.

“MIT has always been a leader in entrepreneurship,” Hockfield says. “Part of leading is sharing with the world. The collaboration with Brown University for this cohort shows that MIT can share our approach with the world, allowing other universities to follow our model of supporting academic entrepreneurship.”

Hickey says that when she and Bhatia asked 30 female faculty members three years ago why they were not commercializing their technologies, many said they had no access to the appropriate networks of mentors, investors, role models, and business partners necessary to begin the journey.

“We encourage you to become this network that has been missing,” Hickey told the awards event audience, which included an array of leaders in the biotech world. “Get to know our amazing faculty members and continue to support them. Become a part of this movement.”

[asianpainacademy]

Relief from Pain: Navigating India's Chronic Pain Fellowship Frontier

In the vast landscape of medical education, the pursuit of specialized knowledge and skills becomes crucial, especially in areas as intricate and challenging as chronic pain management. For medical professionals in India, the quest for expertise in this field often leads to the exploration of chronic pain fellowship programs. Within this journey, the Asian Pain Academy emerges as a beacon, offering a roadmap to navigate the frontier of chronic pain fellowship in India.

Exploring the Chronic Pain Fellowship Frontier:

In the realm of chronic pain management, specialized training is essential to understand the complexities of pain conditions and to deliver effective treatments. The Asian Pain Academy stands at the forefront, providing comprehensive fellowship programs tailored to the unique needs of medical practitioners in India. These programs offer a blend of theoretical knowledge and hands-on experience, equipping fellows with the skills required to address a spectrum of pain disorders.

Participants in the chronic pain fellowship in India offered by the Asian Pain Academy delve into various aspects of pain management, including pharmacological interventions, interventional procedures, psychological approaches, and holistic patient care. Through rigorous training modules and mentorship from seasoned professionals, fellows gain proficiency in assessing, diagnosing, and treating chronic pain conditions, thereby enhancing patient outcomes and quality of life.

Navigating the Path to Expertise:

Embarking on a chronic pain fellowship journey requires guidance and support, which the Asian Pain Academy readily provides. With a network of experienced faculty members and access to state-of-the-art facilities, fellows receive unparalleled mentorship and resources to navigate the complexities of pain management. Moreover, the academy fosters a collaborative learning environment, encouraging knowledge exchange and professional growth among participants.

Conclusion:

In the pursuit of relief from chronic pain, the journey towards expertise is illuminated by institutions like the Asian Pain Academy. Through specialized fellowship programs, medical professionals in India can embark on a transformative path, equipped with the knowledge and skills to make a meaningful difference in the lives of patients suffering from chronic pain conditions. As the demand for specialized pain management grows, the Asian Pain Academy continues to serve as a guiding light, empowering healthcare professionals to navigate the frontier of chronic pain fellowship in India with confidence and compassion.

[doctorweebmd]

board exams tomorrow!!! Wish me luck!!!

[loverboydotcom]

okay i'm glad i did not rush that taxidermy story for the fellowship bc after a few days break from it i am getting new threads...new ideas....

[sobeautifullyobsessed]

Don't mind me - I'm about to watch the last half-hour of Return of the King.